A Controlled Clinical Trial of Cimetidine in the Recurrence of Variceal Hemorrhage: Implications about the Pathogenesis of Hemorrhage
Brian R. D. Macdougall, Roger Williams – 1 January 1983 – In a prospective randomized double‐blind controlled trial, 51 patients, 16 with cirrhosis and 35 with extrahepatic portal hypertension all of whom presented with variceal bleeding, were given either long‐term cimetidine in a dosage of 1.6 gm daily (24 patients) or placebo tablets (27 patients). Thirty‐eight patients completed 2 years of treatment. For 16 patients with cirrhosis, there was no significant difference in the frequency of rebleeding between the cimetidine (62.5%) and placebo (75.0%) groups.